You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HER2 Positive Breast Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Cancer Female, Breast Cancer, Male Trial in Tampa (biological, drug, procedure)

Recruiting
  • Breast Cancer
  • +7 more
  • Dendritic Cell Vaccine (DC1)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 23, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,

Not yet recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +3 more
  • (no location specified)
Jan 24, 2023

HER2 Low Breast Carcinoma Trial (SHR-A1811 for injection)

Not yet recruiting
  • HER2 Low Breast Carcinoma
  • SHR-A1811 for injection
  • (no location specified)
Jun 12, 2023

Metastatic Breast Cancer, HER2 Positive Breast Carcinoma Trial in United States (Niraparib, Trastuzumab)

Recruiting
  • Metastatic Breast Cancer
  • HER2 Positive Breast Carcinoma
  • Birmingham, Alabama
  • +6 more
Dec 13, 2022

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

Completed
Has Results
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 22, 2022

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,

Not yet recruiting
  • Breast Cancer Invasive
  • +3 more
  • Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)

Completed
  • HER2-positive Breast Cancer
  • +5 more
  • Tucson, Arizona
  • +15 more
Dec 22, 2022

HER2-positive Metastatic Breast Cancer, Locally Advanced HER2 Positive Breast Carcinoma Trial in Spain (Tucatinib, Trastuzumab,

Not yet recruiting
  • HER2-positive Metastatic Breast Cancer
  • Locally Advanced HER2 Positive Breast Carcinoma
  • Cádiz, Andalucía, Spain
  • +17 more
Jan 16, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +20 more
  • Best Practice
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 5, 2023

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Yuma, Arizona
  • +5 more
May 25, 2022

Advanced HER2 Negative Breast Carcinoma, HRD+Breast Cancer Trial in Tianjin (fluzoparib+chidamide, fluzoparib+camrelizumab)

Recruiting
  • Advanced HER2 Negative Breast Carcinoma
  • HRD+Breast Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Sep 27, 2022

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +18 more
  • Clinical Encounter
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jul 24, 2023

Breast Cancer Female, Breast Cancer, Male, Breast Cancer Stage I Trial in United States (DC1 Vaccine, WOKVAC Vaccine)

Recruiting
  • Breast Cancer Female
  • +7 more
  • DC1 Vaccine
  • WOKVAC Vaccine
  • Tampa, Florida
  • +6 more
Apr 4, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Washington, Baltimore, Hackensack

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Washington, District of Columbia
  • +4 more
Jan 31, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +5 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jul 14, 2022

Breast Adenocarcinoma, Invasive Breast Carcinoma, Resectable Breast Carcinoma Trial in Jacksonville (Biospecimen Collection,

Recruiting
  • Breast Adenocarcinoma
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective

Recruiting
  • Breast Cancer
  • +2 more
    • Erlangen, Germany
      Department of Gynecology and Obstetrics, Erlangen University Hos
    May 12, 2023

    Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in

    Not yet recruiting
    • Anatomic Stage II Breast Cancer AJCC v8
    • +3 more
    • Biospecimen Collection
    • +7 more
    • Portland, Oregon
      SWOG
    Sep 27, 2023

    Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

    Terminated
    • Estrogen Receptor Positive
    • +16 more
    • Biopsy of Breast
    • +5 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Sep 22, 2022

    HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive NSCLC Trial (XMT-2056)

    Not yet recruiting
    • HER2-positive Breast Cancer
    • +4 more
    • (no location specified)
    Aug 23, 2022